|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Depreciation | ||||
| Stock-based compensation | ||||
| Shares issued for services | ||||
| Loss on conversion of notes | ||||
| Amortization of debt discount | ||||
| Non-cash consideration received pursuant to revenue agreements | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid expense | ||||
| Prepaid expenses and other assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Deferred revenue | ||||
| Net cash used in operating activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from sale of common stock from ATM, net of issuance costs | ||||
| Proceeds from issuance of common stock and warrants, net of issuance costs | ||||
| Proceeds from warrant exercises | ||||
| Proceeds from notes payable | ||||
| Payments of notes payable | ||||
| Issuance costs paid in advance of equity financing | ||||
| Proceeds from short term insurance financing | ||||
| Payments on short term insurance financing | ||||
| Net cash provided by financing activities | ||||
| Net (decrease) increase in cash and cash equivalents | ||||
| Cash and cash equivalents and restricted cash, beginning of period | ||||
| Cash and cash equivalents and restricted cash, end of period | ||||
| Supplemental cash flow information: | ||||
| Cash paid for interest | ||||
| Supplemental non-cash activity | ||||
| Issuance of common stock upon conversion of notes payable | ||||
| Issuance of common stock as commitment fee in advance of equity transaction | ||||
Loading...